HHS kidney-market competition plan sends DaVita down

 

• Axios reported the HHS kidney-care overhaul at approximately noon Eastern.
• The plan seeks fewer barriers to competition and stronger preventive kidney care.
• HHS criticized consolidation, citing DaVita and Fresenius controlling roughly 74% of dialysis.
• DaVita opened about 1% higher before dropping 7.1% during the session.
• Fresenius Medical Care also fell about 2.2%, confirming dialysis-sector pressure.
• DaVita’s decline was nearly triple its recent 2.2%-2.3% daily range.
• Monday’s conference-call notice was routine; third-quarter results remain scheduled October 29.

https://finviz.com/stock?t=DVA&p=d